MJardin Group Announces Medical Cannabis Research Investment in Spain

Collaboration with Salamanca University and the Institute of Neuroscience of Castilla y León to Study the Benefits of Cannabinoids on Epilepsy and Schizophrenia DENVER–(BUSINESS WIRE)–MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR), a leader in cannabis management, today announced its first medical cannabis research investment to fund two studies on the benefits of cannabinoids on […]

Excerpt only …
READ MORE BELOW
Source : NCV spain
Link to original : MJardin Group Announces Medical Cannabis Research Investment in Spain
reposted by Cannabis News World